恩替卡韦

贝加因、恩替卡韦和三苯氧胺与蛋白质、DNA相互作用的电化学研究

Electrochemical Studies on Interactions of Baicalein , Entecavir and Tamoxifen with Protein and DNA

恩替卡韦治疗慢性乙型肝炎1年期疗效

One-year therapeutic effect of Entecavir for treating chronic hepatitis B

含恩替卡韦耐药基因的HBV全基因组逆转录病毒载体的构建及包装

Construction of full-length genome hepatitis virus B plasmid with entecavir drug-resistance gene

恩替卡韦（entecavir，ETV）是环戊基鸟苷类似物，作为一个新的抗HBV有效的药物，最近获得美国FDA上市的批准。

Entecavir ( ETV ), a cyclopentyl guanosine analogue , acquired the admission of FDA on sale as an new potent anti-HBV drug recently .

目的评价恩替卡韦对重庆地区拉米夫定治疗失效的CHB患者3年的疗效和安全性。

Objective To evaluate the efficacy and safety of entecavir ( ETV ) in treating lamivudine refractory chronic hepatitis B ( CHB ) patients .

目的评价恩替卡韦（ETV）对拉米夫定（LVD）失效的慢性乙型肝炎（CHB）患者治疗1年的疗效和安全性。

Objective Evaluation of safety and efficacy of one year treatment of entecavir ( ETV ) in Chinese patients with chronic hepatitis B ( CHB ) who had failed to lamivudine ( LVD ) treat - ment .

恩替卡韦联合胸腺五肽治疗慢性乙型肝炎疗效评价

Effect of entecavir in combination with thymopentin on chronic hepatitis B

恩替卡韦治疗乙型肝炎病毒相关性肾炎的疗效观察

Entecavir Treatment of Hepatitis B Virus Associated Nephritis Observed

这类药物的例子包括拉米夫定、恩替卡韦及阿德福韦。

Examples of drugs in the class are lamivudine , entecavir and adefovir .

恩替卡韦抑制乙型肝炎病毒复制型小鼠体内病毒的复制

Entecavir inhibits hepatitis B virus ( HBV ) replication in HBV replication mice

恩替卡韦治疗乙型肝炎的疗效及安全性

Efficacy and safety of entecavir on hepatitis B

恩替卡韦治疗乙型肝炎肝衰竭患者临床研究

Investigation of the liver failure patients infected with hepatitis B virus treated with entecavir

恩替卡韦治疗后出现病毒学突破的慢性乙型肝炎患者的耐药分析

Resistance assay in chronic hepatitis B patients who underwent virological breakthrough during entecavir treatment

乙型肝炎病毒对恩替卡韦耐药的检测和初步耐药规律研究

Detection and Pilot Study of Entecavir Resistant Mutations in Chronic Hepatitis B Patients with Entecavir-refractory

恩替卡韦与拉米夫定对慢性乙型肝炎抗病毒作用与安全性的对照研究

Comparison of antiviral effects and safety between entecavir and lamivudine in patients with chronic hepatitis B

恩替卡韦对慢性乙型肝炎抗病毒治疗的效果分析

Clinical observation about anti-virus therapy of entecavir in treating chronic hepatitis B at the initial stage

恩替卡韦联合苦参素片治疗慢性乙型肝炎41例

Early results of entecavir associated with kushenin to treat chronicity type B hepatitis of 41 patients

恩替卡韦联合复方丹参滴丸治疗慢性乙型肝炎肝纤维化的临床研究

Effect of entecavir combined with compound danshen dripping pill on hepatic fibrosis induced by chronic hepatitis B

恩替卡韦联合乙肝免疫球蛋白预防肝移植术后乙肝再感染

Intramuscular hepatitis B immunoglobulin combined with entecavir for long-term prophylaxis of hepatitis B re-infection after liver transplantation

血清乙肝表面大蛋白在恩替卡韦治疗慢性乙肝中疗效观察的作用研究

Effects of serum hepatitis B virus large surface protein in therapeutic observation of entecavir on chronic hepatitis B

恩替卡韦联合抗乙型肝炎转移因子对慢性乙型肝炎疗效观察

Effect of Anti-HB Transfer Factor and Adefovir Combination Therapy on Patients with Chronic-Hepatitis B and Influence on HBV DNA

结论恩替卡韦治疗慢性重型乙型肝炎具有较好的疗效和安全性。

Conclusion It can be concluded that Entecavir has good therapeutic efficiency and safety in the treatment of chronic severe hepatitis B.

现有的核苷类药物主要包括了拉米夫定、阿德福韦酯、恩替卡韦，它们对于乙肝病患者都具有一定疗效。

The effect of Adefovir dipivoxil therapy on T helper cells associated cytokines in patients with hepatitis Be antigen-positive chronic hepatitis B. ;

恩替卡韦治疗失代偿期乙型肝炎肝硬化中医药治疗肝炎后早期肝硬化疗效的系统评价

Entecavir therapy in patients with decompensated HBV-related cirrhosis Systematic Review of Therapeutic Effects of Traditional Chinese Medicine on Posthepatitic Cirrhosis at Early Stage

人工有机质梯度土壤高光谱反射特性差异性研究梯度洗脱反相高效液相色谱法测定恩替卡韦的有关物质

The Differences of Soil Hyperspectral Reflectance Characteristics of Artificial Grads of Organic Matter Content among Soil Types HPLC determination of related substances in entecavir

《国际肝病》：对于拉米夫定耐药患者来说，更好的选择是拉米夫定联合阿德福韦治疗还是恩替卡韦单药治疗？

Hepatology Digest : For lamivudine resistant patients is it better for them to be put on lamivudine plus adefovir or directly to entecavir solely ?

恩替卡韦组与拉米夫定组的剂量分别为0.5mg/d和100mg/d。疗程为48～96周。

The dosage in the entecavir group and lamivudine group was 0.5 mg / d and 100 mg / d , respectively , and the duration of therapy was 48 ~ 96 weeks .

对349例乙型肝炎疫苗接种及乙型肝炎预防知识知晓度的调查分析恩替卡韦预防和治疗肝癌肝动脉化疗栓塞术中乙肝病毒再激活

Knowledge about Prevention and Vaccination Against Hepatitis B among 349 Vaccine Recipients A clinical study of therapeutic and preventive effects of entecavir on HBV reactivation in transcatheter arterial chemoembolization of patients with liver neoplasms

她说，因为拉米夫定同另一种广泛用于HIV治疗的药物恩曲他滨是同种类型的，它的效果也受到恩替卡韦的抑制。

Because lamivudine is in the same category of HIV therapies as another widely used drug , emtricitabine , its effectiveness is also compromised by entecavir , she says .